Drugs / Tritanrix-HB+Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00263666 Background | Mar 2005 → Feb 2008 | Rotavirus infection | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix-HB+Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00263666 ↗ |
| Modality | Vaccine | “Tritanrix HepB Hib and Polio Sabin vaccines” NCT00263666 ↗ |